Page 12 - Precision Timed Release News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cingulate Inc (CING) Enters Agreement with Societal CDMO and Provides Clinical Update

Cingulate Inc (CING) Enters Agreement with Societal CDMO and Provides Clinical Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoDavid enloeShanej schafferAnn childressMaster services agreementScience to societyDrug administrationCingulate incMedia relationsmelyssa weibleelixir health public relationsExchange commissionSocietal cdmo incSecurities exchangePrecision timed releaseInvestigational new drugAttention deficit

Cingulate Announces Agreement with Societal CDMO and Provides Clinical Update

Cingulate Announces Agreement with Societal CDMO and Provides Clinical Update
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoKansas cityDavid enloeShanej schafferThomas daltonAnn childressMelyssa weibleMaster services agreementScience to societyDrug administrationCingulate incExchange commissionSocietal cdmo incSecurities exchangeElixir health public relations

Cingulate Presents Data for Its Triple-Release Buspirone Product Candidate: CTx-2103

Cingulate Presents Data for Its Triple-Release Buspirone Product Candidate: CTx-2103
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKansas cityMatthew bramsPsych congressCingulate incMedia relationsmelyssa weibleelixir health public relationsPlatform technologyNational alliance on mental illnessPublic healthExchange commissionSecurities exchangeDemonstrated abilitySingle administrationTriple release buspironeFuture trials employing cingulatePrecision timed release

Cingulate Presents Data for Its Triple-Release Buspirone Product Candidate: CTx-2103 Seite 1

19.09.2022 - Data Demonstrated Ability of CTx-2103 to Deliver a Single Administration of Triple-Release Buspirone – Setting the Stage for Future Trials Employing Cingulate’s Precision Timed Release (PTR) Technology CTx-2103 has the Potential to be the First . Seite 1

United statesMatthew bramsPsych congressCingulate incPrecision timed releaseNew orleansChief medical officerCingulate presents data for its triple release buspirone product candidate

Cingulate Inc Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update

11.08.2022 - $5 Million of Non-Dilutive FinancingVeteran Biotech Executive Appointed to Board KANSAS CITY, Kan., Aug. 11, 2022 (GLOBE NEWSWIRE) - Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision .

United kingdomMatt krepsScott applebaumThomas daltonPeterj werthMelyssa weibleStanford law schoolRegulatory affairs at trevenaWerth family investment associatesDarrow associatesDrug administrationCingulate incCounsel at vitae pharmaceuticalsResearch development rd expensesExchange commissionElixir health public relations